Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic Arthritis
Panel revises spondyloarthritis treat-to-target recommendationsJune 23, 2017SpondyloarthropathiesPsoriatic Arthritis
Ustekinumab trumps TNF-blockade for enthesitis in patients with psoriatic arthritisJune 17, 2017Psoriatic Arthritis
VIDEO: Rheumatology biosimilars gain U.S. momentumJune 16, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
EULAR program features novel treatments and targets in immune pathways and key overviews of the fieldJune 8, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisOsteoarthritisLupus & Connective Tissue Diseases
Experts endorse routine screening for pediatric psoriasis comorbiditiesMay 30, 2017PediatricsPsoriatic Arthritis
Adalimumab outperforms methotrexate in treating severe pediatric plaque psoriasisMay 17, 2017PediatricsPsoriatic Arthritis
_web.jpg)
